Top Endoprosthesis Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Endoprosthesis Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Endoprosthesis industry players.

Endoprosthesis Market Competitive Landscape

Endoprosthesis companies should focus on utilizing advanced manufacturing technologies such as 3D printing to make offerings more accessible. Investing in the R&D of custom and personalized endoprostheses is also a key opportunity for companies as per this global endoprosthesis market analysis.

Use of advanced additive manufacturing technologies and integration with personalized medicine remains the prime focus of new companies. Here are some startups that could boost the adoption of endoprosthesis in the long run.

  • Restor3d: The 2017-founded startup specializes in the development of 3D-printed orthopedic implants and endoprostheses. The United States-based startup leverages advanced imaging, AI-powered design, and 3D printing to create personalized implants for joint, spine, and trauma surgeries. Restor3d’s scalable platform supports patient-specific manufacturing, making it a key innovator in personalized orthopedics. In April 2025, the company secured USD 38 million in fund raise from existing as well as new investors. The company intended to use these funds for product innovation and new launches in 2025 and 2026.

Top Player’s Company Profiles

  • W. L. Gore & Associates
  • Merit Medical Systems Inc.
  • Stryker (US)
  • Johnson & Johnson Services, Inc. (US)
  • Corin Ltd (UK)
  • Medacta International SA (Switzerland)
  • Exactech, inc. (US)
  • MicroPort Orthopedics Inc. (US)
  • Smith & Nephew (UK)
  • Baumer S.A. (Switzerland)
  • Zimmer Biomet Holdings Inc. (US)
  • B. Braun Melsungen AG (Germany)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Endoprosthesis Market size was valued at USD 12.8 Billion in 2024 and is poised to grow from USD 14.25 Billion in 2025 to USD 33.55 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026–2033). 

Endoprosthesis companies should focus on utilizing advanced manufacturing technologies such as 3D printing to make offerings more accessible. Investing in the R&D of custom and personalized endoprostheses is also a key opportunity for companies as per this global endoprosthesis market analysis. 'Zimmer Biomet Holdings Inc. (USA) ', 'Johnson & Johnson (USA) ', 'Stryker Corporation (USA) ', 'Smith & Nephew plc (UK) ', 'Medtronic plc (Ireland) ', 'B. Braun Melsungen AG (Germany) ', 'MicroPort Orthopedics, Inc. (USA) ', 'Medacta International SA (Switzerland) ', 'Exactech, Inc. (USA) ', 'Corin Ltd (UK) ', 'Baumer S.A. (Switzerland) ', 'Boston Scientific Corporation (USA) ', 'Abbott Laboratories (USA) ', 'Meril Life Sciences Pvt Ltd (India) ', 'Translumina (India/Germany) ', 'W. L. Gore & Associates, Inc. (USA) ', 'Merz Aesthetics (Germany) ', 'Limacorporate S.p.A. (Italy) ', 'Waldemar Link GmbH & Co. KG (Germany) ', 'DJO Global (USA) '

Material innovations such as highly cross-linked polyethylene, titanium alloys, and ceramic composites have significantly enhanced the safety, longevity, and biocompatibility of endoprosthetic implants. These advanced materials reduce wear and tear, improve integration with bone, and minimize the risk of immune rejection or implant loosening. Hence, rising investments in biomaterials and coatings R&D is expected to favor the global endoprosthesis market outlook along with high preference for patient-specific endoprostheses.

Smart and Sensor-Integrated Implants: Smart implants embedded with biosensors to monitor implant performance in real-time are expected to be highly sought-after going forward. These implants can track parameters like load distribution, temperature, pressure, and early signs of infection or implant loosening. Data from such devices can be transmitted to physicians for proactive intervention, improving outcomes and extending implant life. As remote monitoring and AI analytics evolve, this endoprosthesis industry trend is slated to offer new opportunities for market players.

The presence of advanced healthcare infrastructure, high healthcare spending, and widespread access to orthopedic care are primarily helping North America lead endoprosthesis adoption on a global level. Favorable reimbursement policies, quick adoption of advanced healthcare technologies, and an increasing senescent population base are also forecasted to help cement the dominance of this region. High patient awareness and access to skilled orthopedic surgeons are also playing a crucial role in driving revenue generation in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Endoprosthesis Market
Endoprosthesis Market

Report ID: SQMIG35A3032

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE